 |
|
|
| |
PHARMACOKINETIC INTERACTIONS BETWEEN THE HCV PROTEASE INHIBITOR BOCEPREVIR AND SIROLIMUS IN HEALTHY SUBJECTS
|
| |
| |
Reported by Jules Levin
EASL 2013 April 24-28 2013 Amsterdam
Ellen GJ Hulskotte1, Hwa-Ping Feng2, Fengjuan Xuan2, Wen Hong Lin2, Yali Zhu2, Scott Rasmussen3, Joan R Butterton2
1Merck Sharp & Dohme Corp., Oss, The Netherlands; 2Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA; 3Celerion, Lincoln, NE, USA
|
| |
|
|
|
|
|
